These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 19835869

  • 1. Design of clinical trials for therapeutic cancer vaccines development.
    Mackiewicz J, Mackiewicz A.
    Eur J Pharmacol; 2009 Dec 25; 625(1-3):84-9. PubMed ID: 19835869
    [Abstract] [Full Text] [Related]

  • 2. A clinical development paradigm for cancer vaccines and related biologics.
    Hoos A, Parmiani G, Hege K, Sznol M, Loibner H, Eggermont A, Urba W, Blumenstein B, Sacks N, Keilholz U, Nichol G, Cancer Vaccine Clinical Trial Working Group.
    J Immunother; 2007 Jan 25; 30(1):1-15. PubMed ID: 17198079
    [Abstract] [Full Text] [Related]

  • 3. Cell based cancer vaccines: regulatory and commercial development.
    Copier J, Ward S, Dalgleish A.
    Vaccine; 2007 Sep 27; 25 Suppl 2():B35-46. PubMed ID: 17916462
    [Abstract] [Full Text] [Related]

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 27; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 5. Potency assays for therapeutic live whole cell cancer vaccines.
    Petricciani J, Egan W, Vicari G, Furesz J, Schild G.
    Biologicals; 2007 Apr 27; 35(2):107-13. PubMed ID: 16882459
    [Abstract] [Full Text] [Related]

  • 6. Cancer vaccines: clinical development challenges and proposed regulatory approaches for patient access to promising treatments.
    Stebbing J, Wood C, Atkins M, Bukowski R, Litwin S, Bower M, Parsa A, Levitsky H.
    Cancer; 2008 Mar 01; 112(5):955-61. PubMed ID: 18286505
    [Abstract] [Full Text] [Related]

  • 7. Anticancer Drug Development: The Way Forward.
    Connors T.
    Oncologist; 1996 Mar 01; 1(3):180-181. PubMed ID: 10387985
    [Abstract] [Full Text] [Related]

  • 8. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ, Guthmann MD, Gabri MR, Carnero AJ, Alonso DF, Fainboim L, Gomez DE.
    Oncol Rep; 2002 Mar 01; 9(2):267-76. PubMed ID: 11836591
    [Abstract] [Full Text] [Related]

  • 9. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A, Raff AB, Chiriva-Internati M, Chen SY, Kast WM.
    Immunol Rev; 2008 Apr 01; 222():316-27. PubMed ID: 18364011
    [Abstract] [Full Text] [Related]

  • 10. [New advances in clinical trials of cancer vaccines].
    Peng F, Wei YQ.
    Ai Zheng; 2006 Aug 01; 25(8):1059-62. PubMed ID: 16965694
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gene-modified cellular vaccines: technologic aspects and clinical problems.
    Mackiewicz J, Mackiewicz A.
    Transplant Proc; 2010 Oct 01; 42(8):3287-92. PubMed ID: 20970673
    [Abstract] [Full Text] [Related]

  • 13. Improving the efficacy of cancer immunotherapy.
    Copier J, Dalgleish AG, Britten CM, Finke LH, Gaudernack G, Gnjatic S, Kallen K, Kiessling R, Schuessler-Lenz M, Singh H, Talmadge J, Zwierzina H, Håkansson L.
    Eur J Cancer; 2009 May 01; 45(8):1424-31. PubMed ID: 19167214
    [Abstract] [Full Text] [Related]

  • 14. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials.
    Mosolits S, Nilsson B, Mellstedt H.
    Expert Rev Vaccines; 2005 Jun 01; 4(3):329-50. PubMed ID: 16026248
    [Abstract] [Full Text] [Related]

  • 15. Overview of tumor cell-based vaccines.
    Copier J, Dalgleish A.
    Int Rev Immunol; 2006 Jun 01; 25(5-6):297-319. PubMed ID: 17169778
    [Abstract] [Full Text] [Related]

  • 16. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA, Neelapu SS, Kwak LW, Biragyn A.
    Haematologica; 2002 Sep 01; 87(9):989-1001. PubMed ID: 12217812
    [Abstract] [Full Text] [Related]

  • 17. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B, Siegel SE, Kaiser HE.
    Anticancer Res; 1996 Sep 01; 16(2):661-74. PubMed ID: 8687112
    [Abstract] [Full Text] [Related]

  • 18. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.
    Berinstein NL.
    Ann N Y Acad Sci; 2009 Sep 01; 1174():107-17. PubMed ID: 19769743
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.